TOT BIOPHARM International Company Limited
Equities
1875
HK0000545266
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 HKD | +3.25% | +5.30% | -19.29% |
Mar. 15 | TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | TOT Biopharm's Loss Narrows in January-September Period | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.29% | 152M | |
+2.49% | 96.73B | |
-1.86% | 21.31B | |
-16.61% | 21.21B | |
-5.80% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B | |
-21.79% | 8.56B |
- Stock Market
- Equities
- 1875 Stock
- News TOT BIOPHARM International Company Limited
- TOT Biopharm Narrows Loss on Lower Selling, R&D Expenses in 2021